Ironwood Pharmaceuticals
IRWD
$7.75
Share price
-1.65%
Change (1 day)
-27.37%
Change (1 year)
Categories
Ironwood Pharmaceuticals (IRWD) - P/B ratio
P/B ratio as of May 2024 : -3.56
According to Ironwood Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of -3.56.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ironwood Pharmaceuticals - P/B ratio (from 2010 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -5.16 | -277.04% |
| 2022-12-31 | 2.91 | -7.49% |
| 2021-12-31 | 3.15 | -89.18% |
| 2020-12-31 | 29.1 | -229.46% |
| 2019-12-31 | -22.5 | 176.02% |
| 2018-12-31 | -8.15 | -103.95% |
| 2017-12-31 | 206 | 585.59% |
| 2016-12-31 | 30.1 | 93.7% |
| 2015-12-31 | 15.5 | -28.19% |
| 2014-12-31 | 21.6 | -30.79% |
| 2013-12-31 | 31.2 | 418.76% |
| 2012-12-31 | 6.02 | -7.74% |
| 2011-12-31 | 6.52 | 108.65% |
| 2010-12-31 | 3.13 | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | 6.27 | -276.35% | 🇬🇧 UK |
 Nektar Therapeutics
NKTR | 2.05 | -157.53% | 🇺🇸 USA |